Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(30%)
Results Posted
33%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
1
10%
Ph phase_2
5
50%
Ph early_phase_1
3
30%

Phase Distribution

4

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
3(33.3%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
5(55.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 13 (33.3%)
Phase 11 (11.1%)
Phase 25 (55.6%)

Trials by Status

recruiting330%
terminated110%
completed660%

Recent Activity

3 active trials
Showing 5 of 10
completedphase_2

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

NCT04414930
recruitingearly_phase_1

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

NCT05011760
recruitingphase_2

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

NCT05790239
completedphase_2

Targeting Anhedonia in Cocaine Use Disorder

NCT02773212
recruiting

Substance Abuse Pre-Treatment Screening Study

NCT00439049
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04414930Phase 2

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

Completed
NCT05011760Early Phase 1

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

Recruiting
NCT05790239Phase 2

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Recruiting
NCT02773212Phase 2

Targeting Anhedonia in Cocaine Use Disorder

Completed
NCT00439049

Substance Abuse Pre-Treatment Screening Study

Recruiting
NCT03606473Early Phase 1

Brain Mechanisms in Young Adults

Completed
NCT03349606Early Phase 1

Cocaine Use Disorder and Cortical Dopamine

Completed
NCT03200080Phase 1

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Terminated
NCT00000308Phase 2

Dextroamphetamine-Cocaine Behavioral Intervention - 5

Completed
NCT00000304Phase 2

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10